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In	 this	 article	 we	 explore	 the	 recent	 enactment	 of	
evidence-	based	 medicine	 (EBM)	 in	 the	 field	 of	 fertil-
ity	care.	We	aim	to	contribute	to	the	medical	sociology	
literature	 through	an	analysis	of	how	evidence	 is	pro-
duced,	 interpreted	 and	 institutionalised	 in	 a	 relatively	







tensions	 between	 commercialisation	 and	 standardisa-
tion	 in	 the	 enactment	 of	 EBM.	 Extant	 medical	 sociol-
ogy	and	Science	and	Technology	Studies	literature	has	
shown	the	hidden	professional	work	required	to	enact	
randomised	 control	 trials	 in	 practice.	 Our	 analysis	
shows	that	this	hidden	work	is	not	enough	when	there	
is	a	broader	lack	of	standardisation	in	both	clinical	and	



































requires	 high	 levels	 of	 standardisation	 of	 knowledge	
production.
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of	standardisation	(Berg	&	Timmermans,	2000;	Timmermans	&	Berg,	2003)	and	the	social	con-









qualitative,	 observational	 and	 small	 scale)	 as	 producing	 ‘lower	 quality’	 evidence	 has	 fostered	





























BACKGROUND: THE BRITISH FERTILITY BUSINESS AND 
THE RESISTANCE TO EBM
As	fertility	care	developed	in	the	late	1970s	and	1980s,	at	a	time	when	EBM	was	not	yet	accepted	
as	dominant	practice,	all	IVF	treatments	currently	considered	standard	were	initially	introduced	













































parison	 impossible:	 heterogeneous	 patient	 populations,	 different	 laboratory	 practices	 (culture	
conditions,	day	of	transfer	and	number	of	embryo	transferred)	and	technical	differences	in	the	
equipment,	including	various	TLM	systems	and	how	they	are	used.

































































THE EFFECTS OF THE COMMERCIALISATION OF THE IVF 
SECTOR ON EVIDENCE PRODUCTION
Focusing	on	the	challenges	to	evidence	production	as	introduced	above,	our	findings	are	pre-









F I G U R E  1 	 Interviews	with	professionals
Professionals currently working in NHS
fertility clinics











4 Biotechnology company representatives
2 Professional body representatives
1 Bioethicist
1 Patient advocate
2 Clinical research professionals




















pressure	 to	 adopt	 cutting-	edge	 treatments	 and	 technologies,	 developing	 differing	 approaches	
to	 their	use.	Although	these	 treatments	and	technologies	are	offered	before	 the	emergence	of	



































































   | 9ENACTING EBM IN FERTILITY CARE






The	 two	 main	 essential	 criteria	 of	 RCT	 protocols	 are	 randomisation	 and	 blinding.	

















































































   | 11ENACTING EBM IN FERTILITY CARE
The	RCT	outcome	reporting	seems	to	suffer	from	a	similar	confusing	and	even	misleading	rep-
resentation	as	IVF	‘success	rates’	(see	Gerrits,	2016;	Inhorn,	2003),	especially	when	clinics	are	com-




























DISCUSSION: TENSIONS BETWEEN 








different	 nuances	 compared	 to	 how	 this	 is	 presented	 in	 the	 literature	 and	 public	 debate.	 IVF	
professionals	 (both	 working	 in	 NHS	 and	 private	 clinics)	 identify	 the	 lack	 of	 funding	 for	 IVF	
treatments	as	negatively	affecting	clinic	and	patient	willingness	to	participate	in	RCTs.	Due	to	

















































































explore	 the	role	of	commercialisation	 in	 the	adoption	of	EBM,	further	research	 is	required	to	
explore	more	problematic,	risky	or	unsafe	medical	interventions.
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